Results: GHK-Cu alleviated weight loss, improved the disease activity index (DAI), reduced colonic edema and shortening, attenuated inflammatory damage, increased goblet cell numbers, suppressed inflammatory cytokines such as TNF-, IL-6, and IL-1, and promoted mucosal repair
Consistent with previous literature findings of weight loss in rodents following MC4R stimulation [47], mice treated with MT-II demonstrated significant weight loss over the 14-day treatment course
It is usually recommended to have a treatment every four weeks to eliminate the buildup of dead skin cells
A post hoc analysis of the phase IIb trial showed that tirzepatide was associated with a reduction in the level of high-sensitivity ICAM-1, CRP, and YKL-40 after 26 weeks of treatment in a dose-dependent manner [83, 103]
Behavioral support may include guidance for meal planning, setting realistic goals, and managing emotional eating